Tulio de Oliveira

Tulio de Oliveira is a South Africa-based bioinformatician and professor specializing in infectious-disease genomics and genomic surveillance. He directs CERI and KRISP and led collaborative scientific teams involved in identifying and reporting the SARS-CoV-2 Beta and Omicron variants.

Star Mover ranking

Not ranked in News yet

0 points

Sign in to Move Up

Profile

About Tulio de Oliveira

Profile information current to 2026-08-22.

South Africa · Bioinformatician, Professor of bioinformatics · 5 affiliations

Show full profile Hide full profile

Known for: Genomic surveillance of infectious diseases; Viral evolution and genomic epidemiology; SARS-CoV-2 variant detection and reporting; Genomic-surveillance capacity building in Africa
Country: South Africa

Bioinformatician
Professor of bioinformatics

At a glance

He is listed as director of the Centre for Epidemic Response and Innovation and the KwaZulu-Natal Research Innovation and Sequencing Platform.
His work focuses on infectious-disease genomics, viral evolution and genomic epidemiology.
During the COVID-19 pandemic, he led collaborative teams associated with identifying and reporting the Beta and Omicron variants in southern Africa.
His institutional and project leadership includes efforts to strengthen genomic-surveillance capacity across African countries.

Genomic-surveillance leadership

De Oliveira directs the Centre for Epidemic Response and Innovation at Stellenbosch University and the KwaZulu-Natal Research Innovation and Sequencing Platform at the University of KwaZulu-Natal. Global Health EDCTP3 describes him as the founder of both institutions, which are involved in monitoring emerging pathogens in Africa. He is also listed as a professor of bioinformatics at Stellenbosch University, a fractional professor at the University of KwaZulu-Natal and an affiliate professor at the University of Washington.

COVID-19 variant surveillance

During the COVID-19 pandemic, de Oliveira led collaborative scientific teams associated with identifying and reporting the SARS-CoV-2 Beta and Omicron variants in southern Africa. In November 2021, his genomic-surveillance team announced the detection of the variant later named Omicron, whose rapid regional expansion was subsequently documented by surveillance teams in southern Africa.

Training and research

De Oliveira earned a BSc at the Federal University of Rio Grande do Sul in Brazil and completed MSc and PhD training at the Nelson R. Mandela School of Medicine at the University of KwaZulu-Natal. His stated research interests include viral evolution, virus origins and transmission networks, bioinformatics software, and next-generation sequencing for epidemic research. He was a Marie Curie Research Fellow at the University of Oxford from 2004 to 2006 and a Newton Advanced Fellow associated with the Wellcome Trust Sanger Institute and the University of Edinburgh from 2015 to 2019.

Recognition and capacity building

De Oliveira was named to the inaugural TIME100 Health list in 2024 and received the EDCTP Scientific Leadership Prize for a sub-Saharan African man in 2025. Global Health EDCTP3 also lists him as leading the GenPath Africa project, which is intended to strengthen genomic-surveillance capacity across African countries.

Affiliations

Centre for Epidemic Response and Innovation (CERI), Stellenbosch University Director present
KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal Director present
School for Data Science and Computational Thinking, Stellenbosch University Professor of bioinformatics present
College of Health Sciences, University of KwaZulu-Natal Fractional professor present
Department of Global Health, University of Washington Affiliate professor present

Timeline

2004 Began a Marie Curie Research Fellowship at the University of Oxford, held from 2004 to 2006.
2015 Became a professor at the University of KwaZulu-Natal.
2021-09-23 CERI officially launched with de Oliveira identified as its founding director.
2021-11 His genomic-surveillance team announced detection of the SARS-CoV-2 variant later named Omicron; surveillance teams in southern Africa subsequently documented its rapid expansion.
2024-05-02 Named to the inaugural TIME100 Health list.
2025 Received the EDCTP Scientific Leadership Prize for a sub-Saharan African man.

Additional verified details

Current context

De Oliveira is listed as director of both CERI and KRISP. Current institutional webpages should be rechecked immediately before publication because academic appointments can change.
Global Health EDCTP3 lists de Oliveira as leading the EDCTP3-funded GenPath Africa project, which is intended to strengthen genomic-surveillance capacity across African countries. Project leadership is described as current by Global Health EDCTP3.

Biographical facts

He earned a BSc at the Federal University of Rio Grande do Sul in Brazil and completed MSc and PhD training at the Nelson R. Mandela School of Medicine at the University of KwaZulu-Natal.
His stated research interests include viral evolution under transmission, acquisition and drug-selection pressures; virus origins and transmission networks; bioinformatics software; and next-generation sequencing for epidemic research.
He was a Marie Curie Research Fellow at the University of Oxford from 2004 to 2006 and a Newton Advanced Fellow associated with the Wellcome Trust Sanger Institute and the University of Edinburgh from 2015 to 2019.
Global Health EDCTP3 states that de Oliveira founded KRISP and CERI, South African institutions involved in monitoring emerging pathogens in Africa.
During the COVID-19 pandemic, de Oliveira led collaborative scientific teams associated with identifying and reporting the SARS-CoV-2 Beta and Omicron variants in southern Africa.